Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.

NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older. Menopause. 2015 Jul; 22(7):685-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.